Discovery of 2,4-diaminopyrimidine derivatives as potent inhibitors of FAK capable of activating the Hippo pathway for the treatment of esophageal squamous cell carcinoma

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 911816ea6c179661-LAX IP: 47.97.18.252 UTC time: 2025-02-13T22:00:08+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4